Deferasirox Tablet, Film Coated
Product Images NDC 72603-232

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Deferasirox (NDC 72603-232). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Fig1 (Deferasirox Fig1)

Fig1 (Deferasirox Fig1)
Figure 1 shows changes in Liver Iron Concentration and Serum Ferritin following Deferasirox Tablets for Oral Suspension at dosages ranging from 5 to 30 mg per kg per day in Study 1. The graph indicates the impact of different dosages on LIC and serum ferritin levels.*
FDA Label Image

Package Label-principal Display Panel (90 mg (30 Tablet Bottle))

Package Label-principal Display Panel (90 mg (30 Tablet Bottle))
This is a pharmaceutical product containing Deferasirox Tablets with a dosage of 90 mg per film-coated tablet. The tablets are manufactured by APL Healthcare Limited in India for Northstar Ax LLC based in Memphis, TN. The package includes 30 tablets and recommends storing them at 20° to 25°C. Patients are advised to refer to the provided Medication Guide and keep the medication out of reach of children. More information can be found at www.northstarrndic.com/products or by calling 1-800-206-7821.*
FDA Label Image

Package Label-principal Display Panel (180 mg (30 Tablet Bottle))

Package Label-principal Display Panel (180 mg (30 Tablet Bottle))
This text provides information about Deferasirox tablets, with each film-coated tablet containing 180 mg of the active ingredient. The tablets are manufactured by Northstar Healthcare Holdings Ltd. in Memphis, TN, and distributed by APL Healthcare Limited in Andhra Pradesh, India. The usual dosage instructions are included, along with storage recommendations. Pharmacists are advised to dispense the medication guide to patients separately. The product is from India and the packaging includes a GTIN, serial number, expiry date, and LOT information both in human-readable coding area and 2D printing during packing. Further details can be found on the Northstar Healthcare website or by calling 1-800-206-7621.*
FDA Label Image

Package Label-principal Display Panel (360 mg (30 Tablet Bottle))

Package Label-principal Display Panel (360 mg (30 Tablet Bottle))
The text contains information on Deferasirox 360 mg tablets manufactured in Memphis, TN. It provides dosage instructions, storage guidelines, contact details, and references to medication guides. The tablets are stored at controlled room temperature and are manufactured in Andhra Pradesh, India. Patients are advised to keep drugs out of reach of children and protect them from moisture. The information includes a provision for dispensing a medication guide to each patient.*
FDA Label Image

Chemical Structure (Deferasirox Str)

Chemical Structure (Deferasirox Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.